Skip to main content
. Author manuscript; available in PMC: 2017 May 17.
Published in final edited form as: Ann Surg Oncol. 2015 Mar 6;22(12):3831–3835. doi: 10.1245/s10434-015-4455-x

Table 2.

Distribution of Androgen Receptor expression among other molecular marker subsets*. Association of Characteristics with AR level for all samples with AR level (n=134)

Characteristic AR Level p-value

1 2 3 4
ER/PR
 Positive 3 (13.0) 10 (43.5) 8 (34.8) 2 (8.7) <0.0001
 Negative 65 (73.9) 9 (10.2) 12 (13.6) 2 (2.3)
Triple Negative
 Yes 61 (76.3) 8 (10.0) 9 (11.3) 2 (2.5) <0.0001
 No 14 (25.9) 15 (27.8) 19 (35.2) 6 (11.1)
ALDH1
 Positive 29 (48.3) 12 (20.0) 14 (23.3) 5 (8.3) 0.40
 Negative 46 (62.2) 11 (14.9) 14 (18.9) 3 (4.1)

AR level 1= AR negative

AR level 2= AR weakly positive

AR level 3= AR moderately positive

AR level 4= AR strongly positive

*

Significant difference in AR level for ER/PR positive vs. ER/PR negative – most ER/PR negative have no AR level, whereas most ER/PR positive have weak-strong AR levels Significant difference in AR levels for Triple Negative vs. not TN-most TN tumors have no AR levels whereas most none-TN tumors have weak-strong AR levels

ALDH positivity distribution does not differ significantly between AR levels